ginsenoside f 11/kansè

Lyen an sove nan clipboard la

Chwazi kalite sòt

10 rezilta yo

Composition for preventing or treating liver cancer containing ginsenoside F2

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This application claims the benefit of Korean Patent Application No 10-2016-0099978, filed Aug. 5, 2016, the entirety of which is incorporated herein by reference. TECHNICAL FIELD The present invention relates to a pharmaceutical composition for preventing or treating liver cancer containing

Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS REFERENCE TO RELATED APPLICATIONS This application is a 35 U.S.C. .sctn. 371 National Phase Entry Application from PCT/KR2013/007852, filed on Aug. 30, 2013, and designating the United States, which is incorporated herein by reference in its entirety. TECHNICAL FIELD The present invention

Ginsenoside with anti-cancer activity and the preparation method thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF INVENTION This invention relates to a novel ginsenoside compound derived from ginsenoside Rh2, the preparation methods and the use thereof in treating cancers. BACKGROUND OF INVENTION In the past decades, a number of anti-cancer drugs have been discovered from natural products, which

Ginsenoside chemotherapy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The invention is in the field of therapeutic compositions and methods, particularly chemotherapy of cancer using ginsenosides. BACKGROUND OF THE INVENTION Panax ginseng has served as an important component of traditional Chinese medicine for thousands of years. Recently,

Method for preparing processed ginseng to obtain increased amount of ginsenoside RG5

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This application claims priority upon Korean. Patent application Ser. No. KR 10-2005-00305 19 filed on Apr. 12, 2005, the contents of which are all herein incorporated by this reference in their entireties. All publications, patents, patent applications, databases and other references cited in this

Use of ginseng extract, ginsenoside and ginsenoside derivative in the preparation of medicine or health care product for treating cytomegalovirus infection disorders

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD The invention belongs to the field of medicines, and relates to a medicine or health food for treating human cytomegalovirus infection, particularly to application of ginseng (a traditional Chinese medicine) extracts and derivatives thereof in medicines or health foods for treating

Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNOLOGICAL FIELD OF THE INVENTION This invention relates to a ginsenoside Rg3 pharmaceutical composition and process thereof. TECHNOLOGICAL BACKGROUND OF THE INVENTION Ginsenoside Rg3 is a tetracyclic-triterpene saponin compound existed in Ginseng, with a molecular weight of 784.13. There are two

Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

20(R)-ginsenoside Rg3 polyacylated derivatives, preparation and application thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This application is the U.S. National phase application corresponding to PCT/CN2014/094726 which was assigned an international filing date of Dec. 23, 2014 and associated with publication WO 2016/095249 A1 and which claims priority to Chinese Application 2014107851724 filed on Dec. 17, 2014, the

Anticancer adjuvant containing panaxadiol ginsenocide compound

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS REFERENCE TO RELATED APPLICATIONS This application is a U.S. National Stage Application filed under 35 U.S.C. .sctn. 371 and claims priority to International Application No. PCT/KR2015/006832, filed Jul. 2, 2015, which application claims priority to Korean Application No. 10-2015-0071477,

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye